Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP - Ultragenyx Pharmaceutical (NASDAQ:RARE)

Summary by Benzinga
Open the article to view the coverage from Benzinga

1 Articles

BenzingaBenzinga
Center

Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP - Ultragenyx Pharmaceutical (NASDAQ:RARE)

Open the article to view the coverage from Benzinga

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Saturday, March 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Novato icon

Novato

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal